In-space pharmaceutical manufacturing and hypersonic re-entry vehicles
Space / Defense📍 El Segundo, CAFounded 2020
Current Valuation
$1.0B
as of 2025-Q3
UNICORN
IPO Outlookprivate
Is Varda Space Industries going public?
No. Varda Space Industries has no imminent IPO plans on record. It is still private.
What is Varda Space Industries' valuation in 2026?
Varda Space Industries is valued at $1.0B as of 2025-Q3, set by its Series C ($187M, Jul 2025). That is the last confirmed mark, not a live price — private shares do not trade continuously.
Has Varda Space Industries filed an S-1?
No public S-1 is on file for Varda Space Industries.
Who are Varda Space Industries' investors?
Varda Space Industries' investors include Founders Fund, Khosla Ventures, Lux Capital, Caffeinated Capital, General Catalyst, Peter Thiel and 2 more.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Varda Space Industries manufactures pharmaceuticals in microgravity aboard small orbital capsules, then returns the cargo to Earth via hypersonic re-entry — a dual-use platform that also serves DoD hypersonic-flight testing. Co-founded by SpaceX veteran Will Bruey and Founders Fund partner Delian Asparouhov, Varda has completed three successful re-entry missions (W-1 through W-3) and raised a $187M Series C in July 2025 at unicorn valuation. Defense customers include the US Air Force and Missile Defense Agency.
Company Profile
CEO
Will Bruey
Founded
2020
HQ
El Segundo, CA
Employees
~150
Total Raised
$325M
Growth
Three successful re-entry missions to date
Last Round
Series C — $187M (Jul 2025) · Lead: Natural Capital / Shrug Capital
IPO Status
no imminent plans
Fundraising Status
Series C · $187M · 1y 1mo ago
no imminent plansTotal raised $325M
Secondary Market
Implied price / share
$26.46
Last round price / share
$20.51
vs last round
+29.0%
Open interest
16
Last round price vs secondary price
Secondary price return by period
Implied per-share price from private secondary transactions, as of Jun 2026. This is a point estimate, not a quote — the feed carries no bid, ask or spread, and a secondary print is evidence of what someone paid on that date rather than a live market. Compare across every tracked name →
Latest Funding Round
Round
Amount
Date
Lead Investor
Post-Money
Series C
$187M
Jul 2025
Natural Capital / Shrug Capital
—
Vertical Intelligence — Defense / Aerospace
Federal awards
9
prime contracts, last 36 months
Obligated
$46.85M
top: Department of Defense
Largest award
$27M
Department of Defense
Latest award
2026-01-30
Largest award: STRATFI, SMALL BUSINESS INNOVATIVE RESEARCH, ECONOMICAL REENTRY CAPSULES FOR HYPERSONIC TESTING (FA945323CA035)
Name-verified against recipient "VARDA SPACE INDUSTRIES, INC." on USASpending.gov as of 2026-08-19. Prime awards only — subcontracts and classified work are not visible in the public registry. Verify on USASpending.gov ↗
Talent Signal
Hiring trend
▲ Hiring uptrend
42% of roles posted in last 30d
Open roles
95
via greenhouse
Product-build share
82%
engineering, research, product, design
Trajectory
expanding
heavy product build — 82% of open roles are product-building functions (engineering/research/product) — 39 of 95 open roles are engineering.
No tracked executive churn; open roles trending up.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
Aerodynamics and Flight Mechanics Engineer IIApplications Engineer - EngineeringApplications Engineer - EngineeringApplications Engineering Internship - Spring 2027Automation Engineer - Controls & PythonAvionics Engineering Internship - Spring 2027
Counted from Varda Space Industries's live job board as of 2026-08-17; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Will BrueyDelian Asparouhov
Investors
Founders Fund · Khosla Ventures · Lux Capital · Caffeinated Capital · General Catalyst · Peter Thiel · Shrug Capital · Natural Capital
Products
W-series re-entry capsules (in-space drug crystallization)
Hypersonic re-entry test vehicles (DoD)
Ritonavir + other pharma payloads
Competitors
Redwire Space (RDW) · Space Tango · SpaceLogistics (NGC) · Sierra Space
SpaceDefenseIn-Space ManufacturingUnicorn
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2025-Q3. Refreshed quarterly.